Literature DB >> 20443082

Thrombocytopenia during fondaparinux prophylaxis: HIT or something different?

Giuseppe Re, Cristina Legnani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20443082     DOI： 10.1007/s11739-010-0379-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest.

Authors:  Louis Valiquette; Donald E Low; Allison J McGeer
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

2.  Impact of the patient population on the risk for heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J A Sheppard; P Horsewood; P J Simpson; J C Moore; J G Kelton
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

3.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

4.  Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).

Authors:  Eugenia Rota; Mario Bazzan; Giovanni Fantino
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

5.  Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence.

Authors:  A Iorio; M C Vedovati; E Filippucci; G Agnelli
Journal:  Intern Emerg Med       Date:  2007-10       Impact factor: 5.472
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.